Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Aneurysm, Thoracic | 20 | 2024 | 696 | 5.420 |
Why?
|
Aortic Aneurysm | 13 | 2022 | 648 | 2.920 |
Why?
|
Marfan Syndrome | 11 | 2021 | 236 | 2.080 |
Why?
|
Coronary Vessel Anomalies | 5 | 2022 | 307 | 1.500 |
Why?
|
Loeys-Dietz Syndrome | 7 | 2022 | 40 | 1.480 |
Why?
|
Aortic Diseases | 5 | 2023 | 735 | 1.420 |
Why?
|
Ehlers-Danlos Syndrome | 2 | 2021 | 93 | 1.390 |
Why?
|
Smad4 Protein | 9 | 2024 | 191 | 1.280 |
Why?
|
Aorta | 13 | 2024 | 2041 | 1.190 |
Why?
|
Muscle, Smooth, Vascular | 6 | 2022 | 1492 | 1.160 |
Why?
|
Hand Deformities, Congenital | 8 | 2024 | 174 | 1.080 |
Why?
|
Cardiovascular Abnormalities | 2 | 2017 | 143 | 1.040 |
Why?
|
Vascular Diseases | 5 | 2022 | 1160 | 1.030 |
Why?
|
Cryptorchidism | 7 | 2024 | 151 | 0.900 |
Why?
|
Transforming Growth Factor beta | 8 | 2022 | 1963 | 0.750 |
Why?
|
Aorta, Thoracic | 6 | 2024 | 1096 | 0.700 |
Why?
|
Aortic Coarctation | 1 | 2022 | 275 | 0.700 |
Why?
|
Growth Disorders | 7 | 2024 | 634 | 0.680 |
Why?
|
Phenotype | 19 | 2024 | 16571 | 0.620 |
Why?
|
Weill-Marchesani Syndrome | 1 | 2017 | 6 | 0.590 |
Why?
|
Histone Deacetylases | 2 | 2019 | 719 | 0.550 |
Why?
|
Myocytes, Smooth Muscle | 6 | 2023 | 699 | 0.550 |
Why?
|
Mutation | 18 | 2024 | 30016 | 0.540 |
Why?
|
Transforming Growth Factor beta2 | 2 | 2018 | 71 | 0.540 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2018 | 431 | 0.530 |
Why?
|
Indazoles | 1 | 2018 | 304 | 0.530 |
Why?
|
Aortic Rupture | 2 | 2016 | 319 | 0.520 |
Why?
|
Genetic Predisposition to Disease | 9 | 2024 | 17878 | 0.470 |
Why?
|
Facies | 8 | 2024 | 222 | 0.460 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2018 | 1241 | 0.410 |
Why?
|
DNA Helicases | 1 | 2018 | 851 | 0.410 |
Why?
|
Pyridones | 1 | 2018 | 808 | 0.410 |
Why?
|
Extracellular Matrix | 1 | 2020 | 1718 | 0.400 |
Why?
|
Active Transport, Cell Nucleus | 3 | 2002 | 433 | 0.400 |
Why?
|
Genetic Testing | 3 | 2021 | 3533 | 0.370 |
Why?
|
Nuclear Proteins | 4 | 2018 | 5789 | 0.370 |
Why?
|
Repressor Proteins | 2 | 2019 | 2985 | 0.360 |
Why?
|
Smad2 Protein | 4 | 2019 | 145 | 0.350 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4110 | 0.330 |
Why?
|
Genetic Association Studies | 4 | 2024 | 2734 | 0.250 |
Why?
|
Nuclear Pore | 2 | 2002 | 62 | 0.240 |
Why?
|
Nucleocytoplasmic Transport Proteins | 2 | 2002 | 73 | 0.240 |
Why?
|
Craniosynostoses | 2 | 2022 | 412 | 0.230 |
Why?
|
Pedigree | 3 | 2018 | 4539 | 0.230 |
Why?
|
Karyopherins | 2 | 2002 | 133 | 0.230 |
Why?
|
Muscle Contraction | 2 | 2019 | 1200 | 0.220 |
Why?
|
Humans | 68 | 2024 | 760617 | 0.220 |
Why?
|
alpha Karyopherins | 1 | 2002 | 40 | 0.210 |
Why?
|
RNA, Nuclear | 1 | 2022 | 29 | 0.210 |
Why?
|
beta Karyopherins | 1 | 2002 | 46 | 0.200 |
Why?
|
Fibrillar Collagens | 1 | 2022 | 42 | 0.200 |
Why?
|
Disease Models, Animal | 11 | 2021 | 18221 | 0.200 |
Why?
|
Actinin | 1 | 2022 | 163 | 0.190 |
Why?
|
Collagen Type III | 1 | 2021 | 91 | 0.190 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2002 | 163 | 0.190 |
Why?
|
Eukaryotic Cells | 1 | 2002 | 191 | 0.190 |
Why?
|
Smad3 Protein | 2 | 2019 | 166 | 0.190 |
Why?
|
Mosaicism | 1 | 2024 | 474 | 0.180 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2019 | 153 | 0.180 |
Why?
|
DNA | 1 | 2014 | 7196 | 0.180 |
Why?
|
Losartan | 3 | 2018 | 263 | 0.180 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2022 | 141 | 0.180 |
Why?
|
Microfilament Proteins | 2 | 2018 | 1130 | 0.170 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2002 | 858 | 0.170 |
Why?
|
MicroRNAs | 3 | 2023 | 3805 | 0.170 |
Why?
|
Neck Pain | 1 | 2021 | 190 | 0.170 |
Why?
|
Male | 36 | 2024 | 360358 | 0.170 |
Why?
|
Connective Tissue Diseases | 1 | 2022 | 285 | 0.170 |
Why?
|
Angiotensin II | 2 | 2013 | 849 | 0.170 |
Why?
|
Animals | 23 | 2023 | 168201 | 0.170 |
Why?
|
Mice, Knockout | 5 | 2019 | 14389 | 0.160 |
Why?
|
Cytokines | 1 | 2014 | 7373 | 0.160 |
Why?
|
Aneurysm | 1 | 2022 | 337 | 0.160 |
Why?
|
Mice | 16 | 2022 | 81368 | 0.160 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3419 | 0.160 |
Why?
|
Dilatation, Pathologic | 4 | 2024 | 527 | 0.160 |
Why?
|
Heterozygote | 4 | 2019 | 2780 | 0.160 |
Why?
|
Echocardiography | 4 | 2022 | 4987 | 0.150 |
Why?
|
Hospitals, General | 2 | 2024 | 798 | 0.150 |
Why?
|
Transcription Factors | 1 | 2018 | 12116 | 0.150 |
Why?
|
Dissection | 1 | 2020 | 297 | 0.150 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2018 | 44 | 0.150 |
Why?
|
Virus Internalization | 1 | 2021 | 497 | 0.150 |
Why?
|
Heredity | 1 | 2018 | 148 | 0.150 |
Why?
|
Histones | 2 | 2018 | 2577 | 0.140 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2017 | 61 | 0.140 |
Why?
|
Actomyosin | 1 | 2018 | 109 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 829 | 0.140 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2019 | 123 | 0.140 |
Why?
|
Sacroiliitis | 1 | 2016 | 10 | 0.140 |
Why?
|
Models, Cardiovascular | 1 | 2022 | 981 | 0.140 |
Why?
|
HLA-B27 Antigen | 1 | 2016 | 63 | 0.140 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 1066 | 0.140 |
Why?
|
Female | 33 | 2024 | 392148 | 0.140 |
Why?
|
Heart Defects, Congenital | 3 | 2022 | 4671 | 0.140 |
Why?
|
Signal Transduction | 9 | 2019 | 23416 | 0.140 |
Why?
|
Cerebral Infarction | 1 | 2021 | 980 | 0.140 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11874 | 0.130 |
Why?
|
Tetralogy of Fallot | 1 | 2022 | 618 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2022 | 829 | 0.130 |
Why?
|
Germ-Line Mutation | 1 | 2024 | 1852 | 0.130 |
Why?
|
Spondylitis, Ankylosing | 1 | 2016 | 155 | 0.120 |
Why?
|
Gene Knockout Techniques | 1 | 2018 | 801 | 0.120 |
Why?
|
Estrogens | 1 | 2021 | 1521 | 0.120 |
Why?
|
Fluorescent Antibody Technique | 2 | 2018 | 2467 | 0.120 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2014 | 0.120 |
Why?
|
Risk Factors | 12 | 2024 | 74115 | 0.120 |
Why?
|
Chest Pain | 2 | 2019 | 1091 | 0.120 |
Why?
|
Antihypertensive Agents | 2 | 2021 | 2016 | 0.110 |
Why?
|
ran GTP-Binding Protein | 3 | 2002 | 53 | 0.110 |
Why?
|
Mice, Mutant Strains | 2 | 2019 | 1748 | 0.110 |
Why?
|
GTPase-Activating Proteins | 3 | 2019 | 471 | 0.110 |
Why?
|
Arthritis, Psoriatic | 1 | 2016 | 219 | 0.110 |
Why?
|
Aortic Valve | 3 | 2018 | 1955 | 0.110 |
Why?
|
Haploinsufficiency | 2 | 2013 | 336 | 0.110 |
Why?
|
Heart Valve Diseases | 2 | 2018 | 1028 | 0.110 |
Why?
|
Syndrome | 3 | 2021 | 3268 | 0.110 |
Why?
|
DNA Methylation | 2 | 2018 | 4391 | 0.110 |
Why?
|
Middle Aged | 20 | 2024 | 220584 | 0.110 |
Why?
|
Headache | 1 | 2021 | 1255 | 0.110 |
Why?
|
American Heart Association | 1 | 2018 | 1039 | 0.110 |
Why?
|
Cell Nucleus | 2 | 2018 | 2894 | 0.110 |
Why?
|
Arachnodactyly | 1 | 2012 | 10 | 0.110 |
Why?
|
Coronary Angiography | 3 | 2019 | 4470 | 0.100 |
Why?
|
Genome-Wide Association Study | 5 | 2022 | 12661 | 0.100 |
Why?
|
Muscle Proteins | 1 | 2018 | 1152 | 0.100 |
Why?
|
Massachusetts | 4 | 2024 | 8833 | 0.100 |
Why?
|
Calcium Channel Blockers | 1 | 2015 | 694 | 0.100 |
Why?
|
Lamin Type A | 1 | 2013 | 186 | 0.100 |
Why?
|
Genetic Markers | 1 | 2018 | 2601 | 0.100 |
Why?
|
Adult | 18 | 2024 | 220969 | 0.100 |
Why?
|
Carrier Proteins | 2 | 2002 | 4935 | 0.090 |
Why?
|
Progeria | 1 | 2013 | 188 | 0.090 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 12966 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 5 | 2023 | 36402 | 0.090 |
Why?
|
Macromolecular Substances | 3 | 2002 | 1433 | 0.090 |
Why?
|
DNA Damage | 1 | 2021 | 2446 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 4570 | 0.090 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 918 | 0.090 |
Why?
|
Heparin | 1 | 2018 | 1632 | 0.090 |
Why?
|
Registries | 4 | 2022 | 8207 | 0.090 |
Why?
|
Exons | 1 | 2016 | 2381 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2019 | 1365 | 0.090 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2016 | 2509 | 0.090 |
Why?
|
Aortic Valve Stenosis | 1 | 2022 | 2003 | 0.090 |
Why?
|
Elastin | 1 | 2011 | 298 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 472 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 476 | 0.080 |
Why?
|
RNA Interference | 1 | 2018 | 2830 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2802 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2024 | 3634 | 0.080 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2016 | 1048 | 0.080 |
Why?
|
Constriction, Pathologic | 2 | 2022 | 1096 | 0.080 |
Why?
|
Boston | 2 | 2019 | 9313 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2022 | 15251 | 0.080 |
Why?
|
MAP Kinase Signaling System | 2 | 2015 | 1483 | 0.080 |
Why?
|
Atherosclerosis | 3 | 2019 | 3400 | 0.070 |
Why?
|
Genomics | 1 | 2023 | 5822 | 0.070 |
Why?
|
Mitochondria | 1 | 2021 | 3619 | 0.070 |
Why?
|
Receptors, Transforming Growth Factor beta | 2 | 2022 | 302 | 0.070 |
Why?
|
Cytoplasm | 2 | 2002 | 1503 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2022 | 20556 | 0.070 |
Why?
|
Cell Line | 4 | 2018 | 15576 | 0.070 |
Why?
|
Cells, Cultured | 6 | 2023 | 18937 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 22115 | 0.070 |
Why?
|
Chromatin | 1 | 2018 | 2955 | 0.070 |
Why?
|
Prospective Studies | 4 | 2021 | 54360 | 0.070 |
Why?
|
Regenerative Medicine | 1 | 2009 | 306 | 0.070 |
Why?
|
Transposition of Great Vessels | 1 | 2010 | 580 | 0.060 |
Why?
|
Databases, Factual | 2 | 2018 | 7960 | 0.060 |
Why?
|
Protein Structure, Tertiary | 2 | 2002 | 3792 | 0.060 |
Why?
|
Catheterization | 1 | 2010 | 1428 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8998 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2018 | 64568 | 0.060 |
Why?
|
Aged | 12 | 2024 | 169042 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3794 | 0.060 |
Why?
|
Clubfoot | 1 | 2024 | 87 | 0.050 |
Why?
|
Cellular Apoptosis Susceptibility Protein | 1 | 2002 | 5 | 0.050 |
Why?
|
Ultrasonography | 1 | 2016 | 5964 | 0.050 |
Why?
|
Biological Transport | 3 | 2021 | 2089 | 0.050 |
Why?
|
Disease Progression | 3 | 2014 | 13495 | 0.050 |
Why?
|
Protein Binding | 4 | 2002 | 9345 | 0.050 |
Why?
|
Child | 4 | 2024 | 80079 | 0.050 |
Why?
|
Intestinal Polyposis | 1 | 2022 | 42 | 0.050 |
Why?
|
Body Weights and Measures | 1 | 2022 | 208 | 0.050 |
Why?
|
Adipokines | 1 | 2024 | 308 | 0.050 |
Why?
|
Survival Rate | 1 | 2016 | 12719 | 0.050 |
Why?
|
Cell Compartmentation | 1 | 2002 | 384 | 0.050 |
Why?
|
Tunicamycin | 1 | 2021 | 108 | 0.050 |
Why?
|
Young Adult | 5 | 2024 | 59179 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10199 | 0.050 |
Why?
|
Coated Pits, Cell-Membrane | 1 | 2001 | 74 | 0.050 |
Why?
|
Child, Preschool | 3 | 2024 | 42188 | 0.050 |
Why?
|
Endosomes | 2 | 2001 | 522 | 0.050 |
Why?
|
Saccharomyces | 1 | 2001 | 63 | 0.050 |
Why?
|
Cytoplasmic Vesicles | 1 | 2001 | 73 | 0.050 |
Why?
|
Caveolins | 1 | 2001 | 102 | 0.050 |
Why?
|
Lung | 1 | 2019 | 9998 | 0.050 |
Why?
|
Dimerization | 1 | 2002 | 890 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9712 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2024 | 2570 | 0.040 |
Why?
|
Guanosine Triphosphate | 1 | 2001 | 316 | 0.040 |
Why?
|
Langerhans Cells | 1 | 2001 | 170 | 0.040 |
Why?
|
Two-Hybrid System Techniques | 1 | 2001 | 460 | 0.040 |
Why?
|
Connective Tissue | 1 | 2022 | 419 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2012 | 4512 | 0.040 |
Why?
|
Clathrin | 1 | 2001 | 257 | 0.040 |
Why?
|
Aortic Valve Prolapse | 1 | 2019 | 10 | 0.040 |
Why?
|
Janus Kinase 2 | 1 | 2023 | 560 | 0.040 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 245 | 0.040 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2000 | 201 | 0.040 |
Why?
|
Recurrence | 3 | 2017 | 8426 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2022 | 14591 | 0.040 |
Why?
|
ROC Curve | 2 | 2019 | 3575 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 2001 | 404 | 0.040 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2019 | 53 | 0.040 |
Why?
|
Neural Crest | 1 | 2022 | 279 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2023 | 927 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 2001 | 658 | 0.040 |
Why?
|
Adolescent | 4 | 2024 | 88234 | 0.040 |
Why?
|
Siblings | 1 | 2022 | 824 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2021 | 437 | 0.040 |
Why?
|
Glycosylation | 1 | 2021 | 1098 | 0.040 |
Why?
|
Stem Cells | 2 | 2009 | 3516 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2002 | 569 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6403 | 0.040 |
Why?
|
Molecular Structure | 1 | 2002 | 1878 | 0.040 |
Why?
|
Stroke Volume | 2 | 2022 | 5486 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2022 | 617 | 0.040 |
Why?
|
Age of Onset | 2 | 2016 | 3302 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39063 | 0.040 |
Why?
|
Heart Failure | 1 | 2021 | 11669 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2001 | 1790 | 0.040 |
Why?
|
Endocytosis | 1 | 2001 | 955 | 0.030 |
Why?
|
Sacroiliac Joint | 1 | 2016 | 57 | 0.030 |
Why?
|
HeLa Cells | 1 | 2002 | 3087 | 0.030 |
Why?
|
Hydralazine | 1 | 2015 | 34 | 0.030 |
Why?
|
Genes, Dominant | 2 | 2013 | 851 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 266 | 0.030 |
Why?
|
Cough | 1 | 2019 | 595 | 0.030 |
Why?
|
Fibroblasts | 3 | 2013 | 4137 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 29600 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1635 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9586 | 0.030 |
Why?
|
Polysaccharides | 1 | 2021 | 1013 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1683 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2001 | 1348 | 0.030 |
Why?
|
Risk Assessment | 3 | 2024 | 23972 | 0.030 |
Why?
|
Zebrafish | 2 | 2018 | 3007 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2661 | 0.030 |
Why?
|
Pulmonary Emphysema | 1 | 2019 | 684 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2278 | 0.030 |
Why?
|
Protein Modification, Translational | 1 | 2013 | 21 | 0.030 |
Why?
|
Death, Sudden | 1 | 2015 | 301 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 2112 | 0.030 |
Why?
|
Farnesyltranstransferase | 1 | 2013 | 71 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2017 | 13441 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2013 | 370 | 0.030 |
Why?
|
Neoplasms | 2 | 2019 | 22131 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 80566 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2001 | 1896 | 0.030 |
Why?
|
Nuclear Envelope | 1 | 2013 | 162 | 0.020 |
Why?
|
Cholesterol | 1 | 2001 | 2903 | 0.020 |
Why?
|
Cardiovascular Agents | 1 | 2018 | 839 | 0.020 |
Why?
|
Dyspnea | 1 | 2019 | 1347 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2013 | 669 | 0.020 |
Why?
|
Prevalence | 2 | 2019 | 15689 | 0.020 |
Why?
|
Models, Molecular | 1 | 2021 | 5433 | 0.020 |
Why?
|
Diphenylamine | 1 | 2011 | 49 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 71 | 0.020 |
Why?
|
Anthracenes | 1 | 2011 | 83 | 0.020 |
Why?
|
Arthritis | 1 | 2016 | 680 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1745 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2002 | 3447 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 770 | 0.020 |
Why?
|
Atrial Septum | 1 | 2010 | 60 | 0.020 |
Why?
|
Cohort Studies | 3 | 2019 | 41457 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2000 | 2674 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 12978 | 0.020 |
Why?
|
Heart | 1 | 2022 | 4403 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2188 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15828 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 3117 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15498 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2022 | 26180 | 0.020 |
Why?
|
Indoles | 1 | 2015 | 1830 | 0.020 |
Why?
|
Microscopy, Electron | 2 | 2001 | 2561 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2023 | 10432 | 0.020 |
Why?
|
Cricetinae | 2 | 2001 | 2424 | 0.020 |
Why?
|
Family | 1 | 2017 | 3193 | 0.020 |
Why?
|
Base Sequence | 1 | 2017 | 12421 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22148 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8472 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2018 | 3548 | 0.020 |
Why?
|
Radiography | 1 | 2016 | 6961 | 0.020 |
Why?
|
Alleles | 1 | 2016 | 6861 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 3591 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10548 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3822 | 0.020 |
Why?
|
Electrocardiography | 1 | 2017 | 6346 | 0.010 |
Why?
|
Risk | 1 | 2015 | 9604 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10073 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3705 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5293 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36152 | 0.010 |
Why?
|
Primaquine | 1 | 2001 | 28 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8311 | 0.010 |
Why?
|
Brefeldin A | 1 | 2001 | 68 | 0.010 |
Why?
|
Sulfonamides | 1 | 2011 | 1977 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9529 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1600 | 0.010 |
Why?
|
Oleic Acid | 1 | 2001 | 92 | 0.010 |
Why?
|
Caco-2 Cells | 1 | 2001 | 363 | 0.010 |
Why?
|
Microscopy, Video | 1 | 2001 | 241 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3204 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20074 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15908 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2002 | 704 | 0.010 |
Why?
|
Androstenes | 1 | 2001 | 181 | 0.010 |
Why?
|
Caveolin 1 | 1 | 2001 | 255 | 0.010 |
Why?
|
Chickens | 1 | 2001 | 858 | 0.010 |
Why?
|
Molecular Probes | 1 | 2000 | 309 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 9050 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2001 | 836 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18381 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 2747 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5835 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2001 | 1434 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2002 | 4172 | 0.010 |
Why?
|
Drug Interactions | 1 | 2001 | 1415 | 0.010 |
Why?
|
United States | 2 | 2018 | 72272 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2010 | 7798 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 29868 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2063 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26049 | 0.010 |
Why?
|
Hypertension | 1 | 2015 | 8529 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2001 | 1970 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2001 | 1132 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5672 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2001 | 2202 | 0.010 |
Why?
|
Antibodies | 1 | 2001 | 2414 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3730 | 0.010 |
Why?
|
Transfection | 1 | 2000 | 5766 | 0.010 |
Why?
|
Cell Membrane | 1 | 2001 | 3680 | 0.010 |
Why?
|
Hospitalization | 1 | 2010 | 10704 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2015 | 58894 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2001 | 2722 | 0.010 |
Why?
|
Homeostasis | 1 | 2001 | 3321 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 17629 | 0.000 |
Why?
|